Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...

A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.

Combination therapy using irbesartan and hydrochlorothiazide was shown to effectively lower blood pressure levels in a large group of hypertensive patients. “The INCLUSIVE [Irbesartan/HCTZ blood ...

A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.

Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. The medications are used to control high blood pressure and ...

Rockville, MD - The US FDA Cardiovascular and Renal Drugs Advisory Committee recommended extended use of the combination product irbesartan plus hydrochlorothiazide (Avalide, Bristol-Myers Squibb) for ...

The study was conducted in adult patients aged 18 years or older with moderate hypertension that at enrolment was either untreated for at least 4 weeks or uncontrolled by monotherapy. Monotherapy was ...

Clinical trials have shown that antihypertensive treatment with the angiotensin II receptor blocker (ARB) irbesartan is an effective way of lowering the BP, and the side effects are mild. 8 A number ...